HealthBar Becomes AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring to Complement its Concierge and Drive-Thru Testing Services

MOUNTAIN VIEW, Calif., April 6, 2021 /PRNewswire/ -- Aditx Therapeutics, Inc. (Aditxt) (the "Company") ADTX, a biotech innovation company focused on improving the health of the immune system, today announced that HealthBar will be offering AditxtScore™ for COVID-19 throughout the State of Michigan.

HealthBar provides on-demand healthcare services to consumers and businesses across its service areas. The company offers drive-thru and concierge COVID-19 testing, including rapid, PCR, antibody, and antigen tests. HealthBar also partners with organizations to provide at-location testing for employees as well as an expanding menu of medical services.

As an AditxtScore™ Channel Partner, HealthBar will now offer its consumer and employer clients AditxtScore™ for COVID-19 as an immune monitoring service. This service will complement HealthBar's current offerings and provide key information regarding immunity status. Aditxt's CLIA-certified AditxtScore™ Center will process specimens collected by HealthBar.

Nathan Baar, Founder and CEO of HealthBar, said, "It's crucial that we provide the best testing options available as businesses and schools begin to open across the State of Michigan. Aditxt's unique immune monitoring technology backed by leading experts within the field provides unmatched information on protective immunity against COVID-19 and is a great addition to our roster of tests."

Amro Albanna, co-founder and CEO of Aditxt, added, "As we learn more about COVID-19,  monitoring the immune system will be key to understanding a person's level of immunity. We're excited to begin working with the HealthBar team and expanding our AditxtScore™ Channel Partner network."

For more information on AditxtScore™ and how it can bolster your COVID-19 testing efforts, visit aditxtscore.com.

About Aditx Therapeutics
Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. For more information, please visit: www.aditxt.com

About HealthBar
HealthBar is a custom healthcare services company providing on-demand, concierge medical care to a wide variety of clients and industries. Their goal is to change how healthcare is delivered to provide a more consumer friendly, transparent model of service. Their services can be ordered as a package or independently. Improving access, reducing cost and focusing on healthy lifestyles and habits drive their core mission of reducing an individual's dependence on the healthcare system. You can learn more at www.healthbar.com.

Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Forward looking statements include statements regarding the Company's intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Company's ongoing and planned product development; the Company's intellectual property position; the Company's ability to develop commercial functions; expectations regarding product launch and revenue; the Company's results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as those risks more fully discussed in the section titled "Risk Factors" in the Company's most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company's other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. 

SOURCE Aditx Therapeutics, Inc.